Skip to main content
Livermore
Livermore
ZHEN

biote Corp.

BTMD
Exchange
Nasdaq
Industry
Medicinal Chemicals & Botanical Products
SEC CIK
0001819253

In the last 90 days, biote Corp. insiders filed 1 open-market purchase and 0 sales; 71 institutions reported holding it in 13F filings for Q2 2026, worth $24.8M in total; no superinvestor holds it.

Holders of 5% or more of BTMD

Holders whose latest Schedule 13D or 13G filing reports 5% or more of biote Corp., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of BTMD
HolderLatest formStakeChangeFirst filedLatest filingFiling
Roystone Management Holdings LLC13D14.00%4.62M sharesNewJun 12, 20251 filingJun 12, 2025SEC
Roystone Capital Management LP13G/A12.00%3.93M shares–Mar 18, 20251 filingMar 18, 2025SEC
Agarwal Amit Mohan13G/A8.40%2.40M shares–Sep 18, 20261 filingSep 18, 2026SEC
Bandera Partners LLC13G/A6.40%2.07M shares–May 13, 20261 filingMay 13, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

4 Schedule 13D and 13G filings on biote Corp., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on BTMD
Filed (ET)FilerFormStakeChangeEvent dateFiling
Sep 18, 20269:03 AM ETAgarwal Amit Mohan13G/A8.40%2.40M shares–Sep 10, 2026SEC
May 13, 20264:30 PM ETBandera Partners LLCand 2 others13G/A6.40%2.07M shares–Mar 31, 2026SEC
Jun 12, 20259:17 PM ETRoystone Management Holdings LLCand 3 others13D14.00%4.62M sharesNewJun 5, 2025SEC
Mar 18, 20251:38 PM ETRoystone Capital Management LPand 5 others13G/A12.00%3.93M shares–Mar 13, 2025SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell biote Corp. shares.

No Form 144 notices for biote Corp. are on file.